Works matching IS 00429007 AND DT 2004 AND VI 87 AND IP 2

Results: 14

Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 118, doi. 10.1111/j.1423-0410.2004.00536.x

By:

Castro, V.;
Alberto, F. L.;
Costa, R. N. P.;
Lepikson-Neto, J.;
Gualandro, S. F. M.;
Figueiredo, M. S.;
Annichimo-Bizzacchi, J. M.;
Saad, S. T. O.;
Costa, F. F.

Publication type:

Article

External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5)

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 91, doi. 10.1111/j.1423-0410.2004.00544.x

By:

Pisani, G.;
Cristiano, K.;
Saldanha, J.;
Wirz, M.;
Bisso, G. M.;
C. Mele;
Gentili, G.

Publication type:

Article

Errata.

Published in:: 2004
Publication type:: Correction Notice

Clinical grade cell manipulation.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 65, doi. 10.1111/j.1423-0410.2004.00537.x

By:

Giordano, R.;
Lazzari, L.;
Rebulla, P.

Publication type:

Article

Retraction: Finfer S, Norton R, Bellomo R, Boyce N, French J, Myburch J, on behalf of the SAFE Study Investigators. The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill.Vox Sang2004; 87 (Suppl. 2): S123–S131.

Published in:

2004

By:

Mayr, W.;
Prowse, C.

Publication type:

Erratum

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 82, doi. 10.1111/j.1423-0410.2004.00548.x

By:

Li, J.;
De Korte, D.;
Woolum, M. D.;
Ruane, P. H.;
Keil, S. D.;
Lockerbie, O.;
McLean, R.;
Goodrick, R. P.

Publication type:

Article

Transfusion-transmitted bacterial infection: risks, sources and interventions.

Published in:

2004

By:

Hewitt, P.;
Barbara, J. A. J.;
Hartley, S.;
McDonald, C.

Publication type:

Letter

Platelet characteristic antigens of CD34<sup>+</sup> cells in cryopreserved cord blood: a study of platelet-derived microparticles in transplant processing.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 96, doi. 10.1111/j.1423-0410.2004.00538.x

By:

Liu, B.;
Chen, J. S.;
M. Cao;
Gu, S. L.;
Liao, C.;
Li, D. Z.;
Zhong, H. Z.

Publication type:

Article

High-throughput genotyping of human platelet antigens using the 5′-nuclease assay and minor groove binder probe technology.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 114, doi. 10.1111/j.1423-0410.2004.00539.x

By:

Higgins, M.;
Hughes, A.;
Buzzacott, N.;
Lown, J.

Publication type:

Article

An update on predeposit autologous blood donation and transfusion in Europe.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 105, doi. 10.1111/j.1423-0410.2004.00546.x

By:

Politis, C.;
Richardson, S. C.

Publication type:

Article

LU21: a new high-frequency antigen in the Lutheran blood group system.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 109, doi. 10.1111/j.1423-0410.2004.00542.x

By:

Crew, V. Karamatic;
Poole, J.;
Banks, J.;
Reed, M.;
Daniels, G.

Publication type:

Article

Current status and prospects for gene therapy.

Published in:

Vox Sanguinis, 2004, v. 87, n. 2, p. 73, doi. 10.1111/j.1423-0410.2004.00543.x

By:

Nathwani, A. C.;
Benjamin, R.;
Nienhuis, A. W.;
Davidoff, A. M.

Publication type:

Article

Are current measures to prevent transfusion-associated protozoal infections sufficient?

Published in:: 2004
Publication type:: Other

Diary of Events.

Published in:: Vox Sanguinis, 2004, v. 87, n. 2, p. 139, doi. 10.1111/j.1423-0410.2004.00558.x
Publication type:: Article